Announcements Trials
Browse Landscape

Status

Recruiting 1Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Thoracic 1

Conditions

Lung Neoplasms 1Chromosome Aberrations 1Carcinogenesis 1

Interventions

Specimen Handling 477pembrolizumab 453Magnetic Resonance Spectroscopy 420Carboplatin 332Cyclophosphamide 311Cisplatin 273Biopsy 271Radiotherapy 245Paclitaxel 233Gemcitabine 228Bevacizumab 212Nivolumab 188fludarabine 184venetoclax 179Drug Therapy 170Dexamethasone 158Oxaliplatin 155Blood Specimen Collection 155Injections 153Capecitabine 151Fluorouracil 143Docetaxel 142Radiosurgery 133Standard of Care 132Rituximab 128Pemetrexed 123durvalumab 115atezolizumab 107Leucovorin 107Radiation 106

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Reverse Transcriptase Polymerase Chain Reaction × 1 year × Clear all
NCT00280202 2025-10-24

Detection of Genetic Markers of Lung Cancer

University of Pittsburgh

Recruiting
6,000 enrolled
Thoracic

Chromosome Aberrations, Lung Neoplasms, Carcinogenesis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡